跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 869 条关于
“ND4”
全部
869
临床试验
407
药物
228
机构
2
资讯
232
9个月前
GenSight Biologics Secures French Regulatory Approvals for GS010/LUMEVOQ Gene Therapy in Rare Blindness Disease
10个月前
GenSight Biologics Secures FDA Authorization for Expanded Access Treatment of Rare Blinding Disease
去年
LUMEVOQ Gene Therapy Shows Sustained Vision Improvement in LHON Patients After 5 Years
去年
GenSight's Gene Therapy Shows Better Outcomes When Administered During Dynamic Phase of LHON Disease
2个月前
FDA Probes Sevoflurane-Linked Neurological Complications in Patients of Venezuelan Ancestry
去年
Lenadogene Nolparvovec Shows Sustained Vision Improvement in LHON Patients After 5 Years
9个月前
PolyPid Receives FDA Support for D-PLEX100 NDA Submission Following Positive Pre-NDA Meeting
去年
FDA Filing Accepted for Sunvozertinib in EGFR Exon 20 Insertion-Positive NSCLC
前天
Ocular Therapeutix Clears FDA Pre-NDA Meeting for AXPAXLI in Wet AMD, NDA Submission on Track for Q4 2026
2年前
George Medicines Submits NDA to FDA for GMRx2 Hypertension Treatment
第 1 页,共 24 页
上一页
下一页